UK markets close in 1 hour 55 minutes

Santhera Pharmaceuticals Holding AG (0QN1.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
9.35-0.25 (-2.60%)
As of 06:08PM BST. Market open.
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 347.60%
S&P500 52-week change 325.01%
52-week high 313.83
52-week low 30.00
50-day moving average 39.91
200-day moving average 38.98

Share statistics

Avg vol (3-month) 31.3k
Avg vol (10-day) 31.43k
Shares outstanding 56.44M
Implied shares outstanding 6N/A
Float 84.46M
% held by insiders 121.79%
% held by institutions 13.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.1:1
Last split date 303 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-515.49%

Management effectiveness

Return on assets (ttm)-37.31%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)5.16M
Revenue per share (ttm)0.58
Quarterly revenue growth (yoy)-37.00%
Gross profit (ttm)N/A
EBITDA -39.42M
Net income avi to common (ttm)-64.69M
Diluted EPS (ttm)-1.62
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.67M
Total cash per share (mrq)0.18
Total debt (mrq)41.51M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.14
Book value per share (mrq)-4.65

Cash flow statement

Operating cash flow (ttm)-33.24M
Levered free cash flow (ttm)-8.97M